This paper examines the role of research that seeks to obtain evidence to support evidence-based medicine (EBM), using a case study of research into ear disease in Aboriginal populations, and suggested that in complex situations, perhaps randomised controlled trials are not the answer.

In 2018, a Parliamentary Joint Committee recommended an urgent ban be implemented on the use of predictive genetic test results in life insurance underwriting in Australia. This article evaluates whether the moratorium meets the Parliamentary Committee recommendations, and finds that it falls short in key...

Precision health is an exciting and rapidly developing field that holds the potential to significantly improve the health and wellbeing of individuals, whānau and communities across Aotearoa. The Ministry of Health wants to hear about the opportunities and challenges that exist now and into the...

This white paper highlights the most significant obstacles to accessing radiotherapy cancer care in Australia including access, awareness, and financial burden; and provides three evidence-based recommendations to improve utilisation of radiotherapy and health outcomes for Australians living with cancer.

Antimicrobial resistance is one of the most serious global public health threats of the 21st Century. This paper argues that now is the time for strong and sustained action on antimicrobial resistance, as this may well be the cause of the next global pandemic.

In this paper, the authors propose flexibilities within the current health care system that accommodate the changes imposed by new technologies, as well as continued government incentives to drive more competitive options and alternatives for health care delivery.

This report argues that in order to capitalise on the opportunities to improve health and make use of the ever-increasing volume of health data, Australia must develop an environment that enables the safe and secure use of patient data for legitimate research purposes – balanced...

This audit examines the effectiveness of the Australian Nuclear Science and Technology Organisation’s management of assets involved in the manufacture, production and distribution of nuclear medicines.

Genomics, where all a person’s genes are examined, as well as the interactions of those genes with each other, is proving a powerful tool for medicine. This report explores some of the challenges currently facing this rapidly evolving sector.

From vaccines to antibiotics, health and medical research has improved, extended, and saved lives. In this episode, Torrens University researchers talk about the need to build a new GP model of care for Australia’s rapidly ageing population.

This report identifies a potential roadmap to embed Quality Use of Medicine principles in the aged care sector, with the aim of reducing medication-related harm.

This report examines the opportunities to deliver better health care for Australians through our regulatory and health technology assessment process for both medicines and technologies.

For the 2 million Australians living with rare diseases, access to medicines can be inadequate. This report reassesses 2014 research by the McKell Institute, assessing the state of rare disease therapies in Australia.

This systematic review describes self-reported ethical practices in research conducted in Australia involving Aboriginal and Torres Strait Islander people.

This strategy document represents a clear blueprint for all governments and players in Australia's health system, and is built around five pillars of detailed policy reform.

This report outlines background information on U.S Medicare payment for imaging services in outpatient settings, followed by payment issues, trends and factors that make imaging payment policy difficult. It continues with an enumeration of recent policies designed to control Medicare spending on imaging, and offers...

This study aimed to estimate the financial costs paid by individual medical researchers from meeting the article processing charges (APCs) levied by open access journals in 2019.

This audit examined whether the COVID-19 National Medical Stockpile (NMS) procurement requirement was met through effective planning and governance arrangements.

COVID-19 has left no healthcare system untouched. The aim of this study was to quantify the changes in activity seen in the NSW health system in the first half of 2020.

This report finds that many patients are not fully aware of the level of control they are entitled to when it comes to choosing medication. It suggests that pharmacists could play a greater role in the patient care pathway to support patients make choices about...

This report gives a unique overview of Australian general practice, while also addressing the impact of COVID-19 on general practice and patients.

The specialist referral system is a key operational component of the Australian health system. This briefing argues that moving towards a health service model that places a greater emphasis on the appropriateness of the referral above the profession of the referrer is necessary to bring...

The Commission are developing a National Baseline Report on Quality Use of Medicines and Medicines Safety in response to this initiative. This discussion paper was published to support the public consultation which informed Phase 1 of the National Baseline Report.

Through this position paper, the Australian Healthcare and Hospitals Association argues that as Australia moves toward a post-COVID world, identifying the changes that are needed to form the foundation of a modern, sustainable and resilient healthcare system, focussed on health outcomes and capable of absorbing...

The impact of the COVID-19 pandemic across Australia’s immediate region is still unfolding. This guide represents a snapshot of the situation as at early June 2020.